CDK12 oncogenic variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | CDK12 oncogenic variants | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Midostaurin | |
| FDA (1) | CDK12 oncogenic variants | Prostate Adenocarcinoma | Olaparib | |
| FDA (1) HC (1) | CDK12 oncogenic variants | Prostate Adenocarcinoma | Enzalutamide, Talazoparib |